Century Therapeutics Inc.

NASDAQ: IPSC · Real-Time Price · USD
0.56
0.01 (1.82%)
At close: Aug 15, 2025, 3:59 PM
0.56
-0.07%
After-hours: Aug 15, 2025, 04:00 PM EDT

Century Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
6.59M 2.23M 5.2M n/a
Cost of Revenue
n/a n/a 10.07M 4.58M
Gross Profit
6.59M 2.23M -4.87M -4.58M
Operating Income
-138.14M -146.55M -133.83M -94.88M
Interest Income
13.01M 12.68M 2.99M 898K
Pretax Income
-124.78M -134.79M -130.84M -95.78M
Net Income
-126.57M -136.67M -130.93M -95.82M
Selling & General & Admin
33.16M 34.71M 31.86M 19.23M
Research & Development
107.24M 92.71M 107.17M 75.65M
Other Expenses
4.33M 21.36M 4.42M 377K
Operating Expenses
144.73M 148.78M 139.03M 94.88M
Interest Expense
n/a 540K 1.1M 1.27M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
144.73M 148.78M 139.03M 94.88M
Income Tax Expense
1.79M 1.88M 91K 43K
Shares Outstanding (Basic)
78.65M 59.31M 57.76M 55.01M
Shares Outstanding (Diluted)
78.65M 59.31M 57.76M 55.01M
EPS (Basic)
-1.61 -2.3 -2.27 -1.74
EPS (Diluted)
-1.61 -2.3 -2.27 -1.74
EBITDA
-111.47M -121.21M -119.34M -89.92M
EBIT
-124.78M -134.25M -129.64M -94.51M
Depreciation & Amortization
13.3M 13.04M 10.07M 4.58M